facebook-script

Fast Facts: Find out if
Afrezza® is right for you
through Telemedicine

If you have type 1 or type 2 diabetes,
Afrezza®, the only ultra rapid-acting
inhaled insulin may be an option for you. Learn
how you can find out if Afrezza® is right for
you through UpScript* –a telemedicine platform.

What is UpScript?

UpScript* is a platform that allows you to schedule an appointment and meet with a doctor online. With telemedicine becoming more common, we’ve partnered with UpScript* so that you can meet with a doctor to determine if Afrezza® is right for you.

How do I get an Afrezza® prescription?

Visit getafrezza.com to get started. First, you’ll complete an online medical questionnaire. Then, you’ll have a virtual or phone consultation with a licensed physician. If it’s determined that Afrezza® is right for you, you will then have the choice to have your prescription mailed right to your home or filled at your chosen pharmacy.

Why do I need a consultation?

A consultation with a doctor is required before you can receive prescription medication. Using UpScript*, you can meet with a doctor online to get medication prescribed from the convenience of home.

How does the online consultation work?

During a virtual or phone consultation, one of the U.S.-licensed physicians will review your medical information and determine whether Afrezza® is an appropriate treatment for your type 1 or type 2 diabetes.

Will insurance cover the consultation fee?

The consultation requires payment at the time of service. The consultation fee is $45.

How much will my prescription cost?

If it is determined that Afrezza® is appropriate for you, MannKind offers several options to help you with the cost of Afrezza, depending on the type of insurance you have. With the Afrezza Savings Card, eligible commercially insured patients may pay as little as $35 per month.* Or with the cash pay program, you may be eligible to get Afrezza for as little as $99/month.**

*The Afrezza Savings Program is subject to eligibility criteria and maximum benefit limitations. See www.afrezzasavingscard.com for complete program terms and conditions.

**MannKind also offers a direct purchase program. You may be eligible to get Afrezza for as little as $99/month. For more information, please contact our patient support team at Afrezza Assist 1-844-323-7399, Monday-Friday 8am-8pm ET.

Does UpScript accept FSA or HSA?

Yes, UpScript* accepts payment through your flexible spending account or health savings account. When asked for payment information, pay with an FSA or HSA card.

Will my prescription be sent to my house or a pharmacy?

You can choose where you want your prescription sent. You can have your prescription shipped directly to your home or your pharmacy of choice. If sending to a pharmacy, your prescription will be sent electronically.

Have more questions?

Get more information in our FAQs and
our easy to read Afrezza® A-Z guide

*Third-party website; does not constitute an endorsement or recommendation by MannKind Corporation.

US-AFR-2213

Read more

What is AFREZZA?

AFREZZA is a man-made insulin that is breathed-in through your lungs (inhaled) and is used to control high blood sugar in adults with diabetes mellitus.

  • AFREZZA is not for use to treat diabetic ketoacidosis. AFREZZA must be used with basal insulin in people who have type 1 diabetes mellitus.
  • It is not known if AFREZZA is safe and effective for use in people who smoke. AFREZZA is not for use in people who smoke or have recently stopped smoking (less than 6 months).
  • It is not known if AFREZZA is safe and effective in children under 18 years of age.

Read more

Important Safety Information

What is the most important information I should know about AFREZZA? AFREZZA can cause serious side effects, including:

Sudden lung problems (bronchospasms). In a study, some AFREZZA-treated patients with asthma, whose asthma medication was temporarily withheld, experienced sudden lung problems. Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting AFREZZA, your healthcare provider will give you a breathing test to check how your lungs are working.

 

Important Safety Information(cont’d)

Who should not use Afrezza®?

Do not use Afrezza® if you:

  • Have chronic lung problems such as asthma or COPD.
  • Are allergic to regular human insulin or any of the ingredients in Afrezza®.
  • Are having an episode of low blood sugar (hypoglycemia).

What should I tell my healthcare provider before using Afrezza®?

Before using Afrezza®, tell your healthcare provider about all your medical conditions, including if you:

  • Have lung problems such as asthma or COPD
  • Have or have had lung cancer
  • Are using any inhaled medications
  • Smoke or have recently stopped smoking
  • Have kidney or liver problems
  • Are pregnant, planning to become pregnant, or are breastfeeding. Afrezza® may harm your unborn or breastfeeding baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins or herbal supplements.

Before you start using Afrezza®, talk to your healthcare provider about low blood sugar and how to manage it.

What should I avoid while using Afrezza®?

While using Afrezza® do not:

  • Drive or operate heavy machinery, until you know how Afrezza® affects you.
  • Drink alcohol or use over-the-counter medicines that contain alcohol.
  • Smoke.

What are the possible side effects of Afrezza®?

Afrezza® may cause serious side effects that can lead to death, including:

See “What is the most important information I should know about Afrezza®?”

  • Low blood sugar (hypoglycemia). Signs and symptoms that may indicate low blood sugar include:
    • Dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability or mood change, hunger.
  • Decreased lung function. Your healthcare provider should check how your lungs are working before you start using AFREZZA, 6 months after you start using it, and yearly after that.
  • Lung cancer. In studies of Afrezza® in people with diabetes, lung cancer occurred in a few more people who were taking Afrezza® than in people who were taking other diabetes medications. There were too few cases to know if lung cancer was related to Afrezza®. If you have lung cancer, you and your healthcare provider should decide if you should use Afrezza®.
  • Diabetic ketoacidosis. Talk to your healthcare provider if you have an illness. Your Afrezza® dose or how often you check your blood sugar may need to be changed.
  • Severe allergic reaction (whole body reaction). Get medical help right away if you have any of these signs or symptoms of a severe allergic reaction:
    • A rash over your whole body, trouble breathing, a fast heartbeat, or sweating.
  • Low potassium in your blood (hypokalemia).
  • Heart failure. Taking certain diabetes pills called thiazolidinediones or “TZDs” with Afrezza® may cause heart failure in some people. This can happen even if you have never had heart failure or heart problems before. If you already have heart failure it may get worse while you take TZDs with Afrezza®. Your healthcare provider should monitor you closely while you are taking TZDs with Afrezza®. Tell your healthcare provider if you have any new or worse symptoms of heart failure including:
    • Shortness of breath, swelling of your ankles or feet, sudden weight gain.

Treatment with TZDs and Afrezza® may need to be changed or stopped by your healthcare provider if you have new or worse heart failure.

Get emergency medical help if you have:

• Trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, confusion.

The most common side effects of Afrezza® include:

  • Low blood sugar (hypoglycemia), cough, sore throat

These are not all the possible side effects of Afrezza®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).

Please See Full Prescribing Information, including BOXED WARNING, Medication Guide and Instructions for Use for AFREZZA.


AFREZZA, the Afrezza logo, AFREZZAASSIST, AFREZZAASSIST and logo, MANNKIND, and BLUHALE VIS are registered trademarks of MannKind Corporation. © 2024 MannKind Corporation.
This site is intended for use by U.S. residents only.